SABAs as Reliever Medications in Asthma Management: Evidence-Based Science

The role of as-needed inhaled short-acting β(2)-agonists (SABAs) in the management of asthma has become a subject of debate due to differing opinions in the professional community relating to the use of SABAs. In this article, we summarize the current position of SABAs when used as reliever medicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Amirav, Israel, Garcia, Gabriel, Le, Bao Khac, Barria, Paulina, Levy, Gur, Aggarwal, Bhumika, Fahrbach, Kyle, Martin, Amber, Phansalkar, Abhay, Sriprasart, Thitiwat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244083/
https://www.ncbi.nlm.nih.gov/pubmed/37280414
http://dx.doi.org/10.1007/s12325-023-02543-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244083/
https://www.ncbi.nlm.nih.gov/pubmed/37280414
http://dx.doi.org/10.1007/s12325-023-02543-9

Ejemplares similares